alloxan has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, H | 1 |
| Roomans, GM; Zhang, W | 1 |
2 other study(ies) available for alloxan and vasoactive intestinal peptide
| Article | Year |
|---|---|
[Vasoactive intestinal polypeptide(VIP)- and insulin-producing cells--molecular biology, physiology and pathology].
Topics: Adenoma, Islet Cell; Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; DNA Repair; Humans; Insulin; Islets of Langerhans; Molecular Weight; Pancreatic Neoplasms; Rats; Streptozocin; Vasoactive Intestinal Peptide | 1984 |
Effects of pituitary adenylate cyclase activating polypeptide-27 (PACAP) and vasoactive intestinal polypeptide (VIP) on chloride in HT29 cells studied by X-ray microanalysis.
Topics: Adenylate Cyclase Toxin; Alloxan; Brimonidine Tartrate; Chloride Channels; Chlorides; Egtazic Acid; Electron Probe Microanalysis; Estrenes; HT29 Cells; Humans; Microscopy, Electron, Scanning Transmission; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Potassium; Pyrrolidinones; Quinoxalines; Signal Transduction; Somatostatin; Vasoactive Intestinal Peptide; Virulence Factors, Bordetella | 1999 |